1. Home
  2. DHX vs LCTX Comparison

DHX vs LCTX Comparison

Compare DHX & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

N/A

Current Price

$4.40

Market Cap

212.3M

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.02

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DHX
LCTX
Founded
1991
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
251.4M
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
DHX
LCTX
Price
$4.40
$1.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
★ $6.75
$5.50
AVG Volume (30 Days)
207.1K
★ 1.4M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.15
N/A
Revenue
★ $127,826,000.00
$14,556,000.00
Revenue This Year
N/A
$4.38
Revenue Next Year
$2.24
$10.80
P/E Ratio
$31.00
★ N/A
Revenue Growth
N/A
★ 53.24
52 Week Low
$1.44
$0.88
52 Week High
$5.19
$1.99

Technical Indicators

Market Signals
Indicator
DHX
LCTX
Relative Strength Index (RSI) 42.07 54.42
Support Level $3.80 $1.02
Resistance Level $5.03 $1.05
Average True Range (ATR) 0.29 0.06
MACD -0.06 0.00
Stochastic Oscillator 23.97 72.53

Price Performance

Historical Comparison
DHX
LCTX

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: